Biodesign at Fifteen

article image

Over the past decade and a half, Stanford University’s Biodesign program has evolved from an experiment to see if medtech innovation can be taught to a global influence over medical device development.

So many academic and university based medtech development programs have surfaced over the past several years that it’s easy to forget how seminal a role Stanford University’s Biodesign program has played in such efforts.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: